Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

SHE:300436 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Market Capitalization	14,262	5,203	4,082	6,237	7,626	5,410
Market Cap Growth	226.47%	27.47%	-34.55%	-18.22%	40.97%	16.00%
Enterprise Value	14,538	5,570	4,394	6,256	7,352	5,526
Last Close Price	89.55	32.67	25.63	39.16	48.03	38.64
PE Ratio	-	-	-	-	-	364.91
Forward PE	-	46.43	46.43	46.43	46.43	46.43
PS Ratio	33.09	11.79	9.66	16.17	20.59	14.68
PB Ratio	30.44	13.11	7.17	6.53	7.26	9.30
P/TBV Ratio	144.65	105.00	24.67	8.11	8.81	12.71
P/OCF Ratio	-	251.27	-	-	-	346.83
EV/Sales Ratio	33.73	12.62	10.39	16.22	19.85	15.00
EV/EBITDA Ratio	-	-	-	-	-	151.23
EV/FCF Ratio	-262.97	-	-	-	-	-
Debt / Equity Ratio	0.93	1.12	0.81	0.33	0.18	0.36
Debt / EBITDA Ratio	-	-	-	-	-	5.78
Asset Turnover	0.28	0.29	0.27	0.26	0.30	0.39
Inventory Turnover	1.36	1.79	2.07	2.16	2.09	2.83
Quick Ratio	0.62	0.42	0.50	0.72	1.50	0.64
Current Ratio	1.03	0.71	0.75	0.97	1.82	0.88
Return on Equity (ROE)	-45.15%	-35.71%	-49.17%	-14.02%	-4.19%	2.85%
Return on Assets (ROA)	-6.83%	-5.11%	-8.53%	-9.56%	-4.13%	-0.05%
Return on Capital (ROIC)	-11.24%	-8.35%	-11.55%	-11.23%	-4.99%	-0.06%
Return on Capital Employed (ROCE)	-16.80%	-14.40%	-20.90%	-20.70%	-7.10%	-0.10%
Earnings Yield	-1.38%	-3.00%	-8.54%	-2.04%	-0.46%	0.27%
FCF Yield	-0.39%	-0.89%	-9.21%	-5.06%	-2.52%	-0.72%
Payout Ratio	-	-	-	-	-	59.62%
Buyback Yield / Dilution	0.01%	0.00%	-0.06%	-6.54%	-6.43%	-0.24%
Total Shareholder Return	0.01%	0.00%	-0.06%	-6.54%	-6.43%	-0.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.